Pacira | PCRX - الدائنين التجاريين





الدائنين التجاريين تغيير تاريخ
Assertio Holdings USD 14.66M 3.81M 2025-09
Astellas Pharma JPY 181.95B 13.3B 2025-12
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Cara Therapeutics USD 2.42M 2.42M 2025-06
Coherus Biosciences USD 9.91M 14.98M 2025-12
Heron Therapeutics USD 8.99M 3.02M 2025-12
Ironwood Pharmaceuticals USD 1.61M 224K 2025-09
J&J USD 11.99B 2.37B 2025-12
Ligand Pharmaceuticals USD 3.24M 24.52M 2025-12
Nektar Therapeutics USD 15.56M 1.28M 2025-09
Novo Nordisk DKK 19.76B 4.15B 2025-12
Omeros USD 8.84M 4.42M 2025-06
Pacira USD 15.15M 2.54M 2025-12
Perrigo USD 474.5M 4.8M 2025-12
Pfizer USD 5.02B 142M 2025-09
Supernus Pharmaceuticals USD 107.8M 813K 2025-12
Teva Pharmaceutical Industries USD 2.53B 176M 2025-12
Xeris Pharmaceuticals USD 3.08M 3.45M 2025-12
Xoma USD 2.65M 1.52M 2025-09
Zoetis USD 487M 77M 2025-12